Food, Drugs, Healthcare, Life Sciences

The National Institutes of Health recently instituted a new patent licensing policy aimed at expanding access to new drugs and medical devices.

Artificial intelligence (AI) is transforming health care and biotechnology, propelling advancements in drug discovery, genomics, medical imaging, and personalized medicine.

The strategy, titled, "A Prescription for Action: A Pan-Canadian Strategy for Advancing the Appropriate Use of Prescription Medications" provides a 5-year plan to foster a unified national approach that promotes safer, more effective medication use and strengthens health system sustainability.

The Centers for Medicare and Medicaid Services (CMS) announced that the Clinical Laboratory Improvement Amendments (CLIA) program will be paperless as of March 1, 2026.

In the high-stakes world of healthcare, where every decision can impact lives, leadership is more than just a title, it's a responsibility

On October 23, 2025, FDA released its final guidance regarding Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments.

On October 23, 2025, FDA released its final guidance regarding Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments.

Recent tariff measures affecting pharmaceutical products and ingredients have introduced new compliance and cost considerations for manufacturers, distributors, and importers operating in Canada and abroad.

On October 22, the Senate Special Committee on Aging held a hearing entitled, "Modernizing Health Care: How Shoppable Services Improve Outcomes and Lower Costs.